文獻(xiàn)引用
欣博盛生物科技有限公司（NeoBioscience Technology Co, Ltd）是一家致力于生命科學(xué)和生物技術(shù)領(lǐng)域的高科技企業(yè)，公司由在國內(nèi)科研試劑領(lǐng)域有著十幾年從業(yè)經(jīng)驗(yàn)的專業(yè)技術(shù)團(tuán)隊(duì)和企業(yè)管理團(tuán)隊(duì)組建而成，公司自主研發(fā)的ELISA試劑盒品質(zhì)卓越，行業(yè)領(lǐng)先，在國內(nèi)眾多重點(diǎn)實(shí)驗(yàn)室得到廣泛使用，深受廣大科研工作者的好評(píng)。
欣博盛品牌ELISA自推出以來廣受權(quán)威認(rèn)可，得到多篇SCI文獻(xiàn)引用，其中包括Nature，Nature Immunology，PANS，Cell Research等頂刊文獻(xiàn)引用；同時(shí)有數(shù)千篇國內(nèi)核心期刊、博士及碩士論文引用。
欣博盛生物共有3214篇SCI文獻(xiàn)引用。您可以通過篩選功能查看感興趣的文獻(xiàn)。
| 文獻(xiàn) | 指標(biāo) | 種屬 | 樣本類型 |
|---|---|---|---|
| Yang Zhang, L. X., JiangXuan Li, et al. Improved fat transplantation survival by using the conditioned medium of vascular endothelial growth factor transfected human adipose-derived stem cells. The Kaohsiung Journal of Medical Sciences 2017 May 31 (2017). Link | VEGF | Human | 常規(guī)樣本 |
| Yang W W, Y. L. Q., Zhao F, et al. Epiregulin Promotes Lung Metastasis of Salivary Adenoid Cystic Carcinoma. Theranostics 23 August 2017 (2017). Link | VEGF | Human | 常規(guī)樣本 |
| Wang Q, L. L. H., Li Y Y, et al. Hypoxic Preconditioning Enhances Biological Function of Endothelial Progenitor Cells via Notch-Jagged1 Signaling Pathway. Medical Science Monitor 29 September 2017 (2017). Link | VEGF | Human | 常規(guī)樣本 |
| Jinlian Wei, Y. Y., Yali Li, et al. Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential. BIOORGAN MED CHEM 2017 March 15 (2017). Link | VEGF | Human | 常規(guī)樣本 |
| Wei J, Y. Y., Li Y, et al. Systhesis and evaluation of N-(benzofuran-5-yl) aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential. Bioorganic & Medicinal Chemistry 11 June 2016 (2016). Link | VEGF | Human | 常規(guī)樣本 |
| Shi X F, W. H., Xiao F J, et al. MiRNA-486 regulates angiogenic activity and survival of mesenchymal stem cells under hypoxia through modulating Akt signal. Biochemical and Biophysical Research Communications 12 February 2016 (2016). Link | VEGF | Human | 常規(guī)樣本 |
| Shi J, C. N., Wang S, et al. Overexpression of YB1 C-terminal domain inhibits proliferation, angiogenesis and tumorigenicity in a SK-BR-3 breast cancer xenograft mouse model. FEBS Open Bio 11 January 2016 (2016). Link | VEGF | Human | 常規(guī)樣本 |
| Li T T, S. X., Geng Y, et al. Folate-functionalized magnetic-mesoporous silica nanoparticles for drug/gene co-delivery to potentiate the antitumor efficacy. . ACS applied materials & interfaces 18 May, 2016 (2016). Link | VEGF | Human | 常規(guī)樣本 |
| Zhang X, T. J., Zhi X, et al. . miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer. Oncotarget 2015 Jan 22 (2015). Link | VEGF | Human | 常規(guī)樣本 |
| Yu Y, C. J., Chen R, et al. Enhancement of VEGF-Mediated Angiogenesis by 2-N,6-O-Sulfated Chitosan-Coated Hierarchical PLGA Scaffolds. ACS applied materials & interfaces April 23, 2015 (2015). Link | VEGF | Human | 常規(guī)樣本 |
